[1]
„Compaction and Tableting Behavior of a Novel Co-Processed Excipient in the Formulation of Metoprolol Succinate Tablets“, NJPR, sv. 16, izd. 2, str. 127–142, pros. 2020, doi: 10.4314/njpr.v16i2.4.